These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2898806

  • 1. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
    Nielsen ST, Beninati L, Buonato CB.
    Scand J Gastroenterol; 1988 Apr; 23(3):272-6. PubMed ID: 2898806
    [Abstract] [Full Text] [Related]

  • 2. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
    Tornhamre S, Edenius C, Smedegård G, Sjöquist B, Lindgren JA.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):225-34. PubMed ID: 2572437
    [Abstract] [Full Text] [Related]

  • 3. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
    Craven PA, Pfanstiel J, Saito R, DeRubertis FR.
    Gastroenterology; 1987 Jun 10; 92(6):1998-2008. PubMed ID: 2883067
    [Abstract] [Full Text] [Related]

  • 4. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kumamoto T, Matsuda A, Kataoka M, Kokuba Y.
    Arzneimittelforschung; 1998 Oct 10; 48(10):1007-11. PubMed ID: 9825118
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of antibody secretion by 5-aminosalicylic acid.
    MacDermott RP, Schloemann SR, Bertovich MJ, Nash GS, Peters M, Stenson WF.
    Gastroenterology; 1989 Feb 10; 96(2 Pt 1):442-8. PubMed ID: 2562949
    [Abstract] [Full Text] [Related]

  • 6. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
    Wittenberg HR, Kleemeyer K, Peskar BM, Peskar BA.
    Wien Klin Wochenschr; 1991 Feb 10; 103(2):34-9. PubMed ID: 1673814
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.
    Neal TM, Winterbourn CC, Vissers MC.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2765-8. PubMed ID: 2888463
    [Abstract] [Full Text] [Related]

  • 12. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA.
    Br J Rheumatol; 1995 Nov 01; 34 Suppl 2():16-9. PubMed ID: 8535642
    [Abstract] [Full Text] [Related]

  • 13. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kawasaki M, Matsuda A, Kataoka M, Kokurba Y.
    Arzneimittelforschung; 1998 Dec 01; 48(12):1163-7. PubMed ID: 9893931
    [Abstract] [Full Text] [Related]

  • 14. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
    Stevens C, Lipman M, Fabry S, Moscovitch-Lopatin M, Almawi W, Keresztes S, Peppercorn MA, Strom TB.
    J Pharmacol Exp Ther; 1995 Jan 01; 272(1):399-406. PubMed ID: 7815356
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Release of eicosanoids from human synovial tissue and the effect of anti-inflammatory drugs.
    Wittenberg HR, Kleemeyer K, Hoppe U, Peskar BM, Peskar BA.
    Prog Clin Biol Res; 1987 Jan 01; 242():277-82. PubMed ID: 3118382
    [No Abstract] [Full Text] [Related]

  • 17. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
    Comer SS, Jasin HE.
    J Rheumatol; 1988 Apr 01; 15(4):580-6. PubMed ID: 2899646
    [Abstract] [Full Text] [Related]

  • 18. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system.
    Reynolds PD, Middleton SJ, Shorthouse M, Hunter JO.
    Aliment Pharmacol Ther; 1995 Oct 01; 9(5):491-5. PubMed ID: 8580268
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes.
    Shanahan F, Niederlehner A, MacDermott RP, Stenson WF, Kane MG, Targan S.
    Immunopharmacology; 1986 Apr 01; 11(2):111-8. PubMed ID: 2872187
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.